Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial
Condition: Liver, Cancer of, Primary Resectable Interventions: Drug: Oxaliplatin; Drug: Doxorubicin; Drug: Lobaplatin; Drug: Cisplatin; Drug: Oxaliplatin, Leucovorin, fluorouracil; Drug: Lobaplatin, Raltitrexed Sponsor: Zhujiang Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Eloxatin | Hospitals | Liver | Research | Urology & Nephrology